Subscribe to
our newsletters

Subscribe to our newsletters!

Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.

Search in Nordic Life Science Insight

2017
April
May
June
July
August
September
October
November
December
Select month
20182019

2017

-

September

Date
Title
Category
Company
September 1, 2017
Super Health, Super You
Life Science
Novo Nordisk Pharmatech A/S
September 5, 2017
Roche Medicine Ready to Fight Breast Cancer
Pharma
Oslo Cancer Cluster
September 5, 2017
Photocure’s Promising Combo
Life Science
Oslo Cancer Cluster
September 6, 2017
Novo Nordisk announces conclusion of U.S. federal investigation of marketing practices
Pharma
Novo Nordisk Pharmatech A/S
September 6, 2017
Nanologica and Dr Sabrina Valetti receive a research grant of 2.4 million SEK
Medtech
Nanologica
September 7, 2017
AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
Pharma
AbbVie
September 7, 2017
AbbVie Leads Biotechnology Industry on Dow Jones Sustainability Index for Second Consecutive Year
Biotech
AbbVie
September 11, 2017
Creating a SPARK in Innovation and Industry
Life Science
Oslo Cancer Cluster
September 13, 2017
FDA votes for further warnings for gadolinium-based contrast agents
Life Science
Spago Nanomedical
September 13, 2017
More People Treated With Once-weekly Semaglutide Achieved Reductions in Both Glucose and Weight vs. Comparator Treatments
Pharma
Novo Nordisk Pharmatech A/S
September 13, 2017
InDex Pharmaceuticals gets new patent granted in Japan
Pharma
InDex Pharmaceuticals
September 13, 2017
Introducing Lena Nymo Helli, the new CEO of Abbvie Norway.
Life Science
AbbVie
September 14, 2017
Xultophy® Reduces Cardiovascular Risk Factors in People with Type 2 Diabetes
Pharma
Novo Nordisk Pharmatech A/S
September 15, 2017
Tresiba® Trial Shows that People with Type 2 Diabetes who Avoid Severe Hypoglycaemia have a Reduced Risk of Death
Pharma
Novo Nordisk Pharmatech A/S
September 18, 2017
Immunotherapy: Finding the Right Fit
Life Science
Oslo Cancer Cluster
September 19, 2017
AbbVie Announces Positive Topline Results from Phase 3 Trial Evaluating VENCLEXTA™/VENCLYXTO™ (Venetoclax) Tablets in Combination with Rituxan® (rituximab) for the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Pharma
AbbVie
September 21, 2017
The Innovation Pavilion by Sweden
Life Science
Global Pharma Consulting
September 22, 2017
Young Skills at Thermo Fischer
Life Science
Oslo Cancer Cluster
September 22, 2017
AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid Tumors
Pharma
AbbVie
September 27, 2017
AbbVie Announces Approval of MAVIRET™ (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6) in Japan
Pharma
AbbVie
September 27, 2017
Working Mother names Novo Nordisk one of its "100 Best Companies"
Life Science
Novo Nordisk Pharmatech A/S
September 29, 2017
IDF and Novo Nordisk Launch First-ever Global Survey on Cardiovascular Disease Awareness among People with Type 2 Diabetes
Pharma
Novo Nordisk Pharmatech A/S
September 29, 2017
Missed OCC at Oslo Innovation Week?
Life Science
Oslo Cancer Cluster

Nordic Life Science - Insight

NLS Insight's goal is to assist the Nordic regions leading innovators in targeting business collaborations, parnership opportunities and investment potential.

info@nlsinsight.com
+47 69 51 02 XX
Olaf Helsets vei 5, 0694 Oslo
Mail iconinfo@nlsinsight.com
Phone Icon+47 69 51 01 94
Adress IconOlaf Helsets vei 5, 0694 Oslo
Facebook icon
Twitter icon
LinkedIn icon
Privacy policy
Subscribe to
our newsletters

Designed by Horn Digital Media 2019